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Introduction {#sec005}
============

Non-communicable diseases (NCDs) have been established as the primary cause of morbidity, with a considerable attendant premature mortality burden that disproportionately impacts poor, vulnerable and socio-economically disadvantaged populations within low- and middle-income countries (LMICs) \[[@pone.0236034.ref001]--[@pone.0236034.ref003]\]. Adding to the social, financial and physical burdens associated with management of NCDs is the predominant single-morbidity approach of clinical care guidelines, despite evidence that these diseases seldom occur in isolation, with an increasing proportion of persons experiencing multiple coexisting chronic diseases or multimorbidity (i.e. the co-occurrence of two or more diseases) \[[@pone.0236034.ref004]--[@pone.0236034.ref008]\].

Although a growing body of literature is available on the patterns and clusters of diseases, multimorbidity remains a complex phenomenon, with a vast variety of potential disease combinations that make it difficult to analyze \[[@pone.0236034.ref009]\]. Moreover, in the absence of an established "gold standard" measurement, considerable variation exists in the application of statistical methods to studies of this phenomenon \[[@pone.0236034.ref004],[@pone.0236034.ref009]--[@pone.0236034.ref011]\]. Previous studies have typically relied on simple disease counts to specify whether a person has two or more conditions from a pre-defined list \[[@pone.0236034.ref004],[@pone.0236034.ref010],[@pone.0236034.ref012]\]. Exploratory factor analysis (EFA) and traditional cluster analysis techniques have also emerged as commonly used methods \[[@pone.0236034.ref007]\], with latent class analysis (LCA) being increasingly applied to studies of multimorbidity patterns \[[@pone.0236034.ref009],[@pone.0236034.ref011],[@pone.0236034.ref013]--[@pone.0236034.ref017]\]. Yet, despite recognized---and increasing---methodological diversity, few studies have endeavored to increase the reliability of findings through comparison of statistical techniques.

To date, only two studies have compared multimorbidity patterns identified using different analytic approaches. One study of 408,994 patients aged 45--64 years in Catalonia, Spain extracted diagnoses from electronic health records, using 263 disease blocks of the International Classification of Diseases version 10 (ICD-10), to compare patterns identified via hierarchical cluster analysis and EFA methods \[[@pone.0236034.ref018]\]. Authors concluded that while disease groupings from the two analytic methods did not always match exactly, there was some consistency in multimorbidity patterns \[[@pone.0236034.ref018]\]. The other study used self-reported data on 10 NCDs from a cross-sectional sample of 4,574 Australian adults, 50 years and older, finding consistency in results across four methods (i.e. commonly occurring pairs and triplets of comorbid diseases; cluster analysis of diseases; principal component analysis; LCA) that was suggestive of the co-occurrence of diseases beyond chance \[[@pone.0236034.ref011]\]. Notably, despite evidence of variation in the burden of individual NCDs across population subgroups \[[@pone.0236034.ref001]\], neither study examined sex differences in multimorbidity patterns. However, both studies did emphasize the need to strengthen the evidence base on multimorbidity prevalence and patterns, to better inform disease management and healthcare delivery \[[@pone.0236034.ref011],[@pone.0236034.ref018]\]. International organizations, such as the World Health Organization (WHO), the European Forum for Primary Care and the National Institute for Health and Clinical Excellence (NICE), similarly echo this sentiment noting that knowledge of multimorbidity patterns in a given population is an important first step towards generating an evidence base for actual clinical practice, with significant implications for patient-oriented prevention, diagnosis, treatment, and prognosis \[[@pone.0236034.ref007],[@pone.0236034.ref019],[@pone.0236034.ref020]\].

Throughout WHO regions worldwide, the burden of NCDs is purportedly highest in the Americas, with higher rates among people in the English-speaking Caribbean nations \[[@pone.0236034.ref002],[@pone.0236034.ref021],[@pone.0236034.ref022]\]. Within the Caribbean community, Jamaica has been conducting numerous comprehensive national health surveys, including the Jamaica Health and Lifestyle Surveys 2000/2001 (JHLS-I) and 2007/2008 (JHLS-II) \[[@pone.0236034.ref023]--[@pone.0236034.ref026]\], providing a well-established evidence base of a severe burden of individual NCDs, that is predominantly borne by females \[[@pone.0236034.ref023]--[@pone.0236034.ref027]\]. However, no investigation of multimorbidity prevalence or patterns has yet been undertaken for Jamaica, or the larger Caribbean region.

This study aims to address this research gap via secondary analysis of the JHLS-II dataset. First, LCA was used to describe the prevalence of multimorbidity in the Jamaican population, identify classes of individuals with distinct multimorbidity patterns and examine whether these patterns were similar across sex. Then, to assess the validity and reliability of multimorbidity profiles identified via LCA, EFA was used as a robustness check to compare consistency (or variation) in patterns identified across the two latent modelling techniques. Results from this study will provide nuanced insight into the burden and distribution of co-occurring conditions in the Jamaican population, to inform more targeted prevention and management strategies.

Methods {#sec006}
=======

Sample {#sec007}
------

The JHLS-II is a nationally representative study that was coordinated at the Epidemiology Research Unit (ERU) of the Tropical Medicine Research Institute (TMRI), the University of the West Indies, Mona, recruiting a sample of 2,848 Jamaicans, 15--74 years of age over a four-month period spanning from November 2007 and March 2008, via a multi-stage cluster sampling design \[[@pone.0236034.ref026],[@pone.0236034.ref027]\]. In brief, participant recruitment was based on a random selection of clusters (or enumeration districts) proportionate to the size of the population within the 14 parishes of Jamaica \[[@pone.0236034.ref026]\]. Enumeration districts were determined by the Statistical Institute of Jamaica. Within each cluster, a random starting point was chosen and every 10th household systematically identified, with a single individual from each household being invited to participate \[[@pone.0236034.ref026]\]. An interviewer-administered questionnaire was used to obtain self-reported information on demographic characteristics, medical history and health behaviors. Physical (i.e. height, weight, waist circumference) and biological (i.e. blood pressure, blood glucose, total cholesterol) measurements were made in accordance with standardized protocols \[[@pone.0236034.ref026],[@pone.0236034.ref027]\]. Low non-response rate (1.7%) and maintenance of high inter- and intra-observer reliabilities throughout the survey were indicators of good data quality \[[@pone.0236034.ref026]\]. Further details of the survey design, sampling procedures and data collection methods are provided in the technical report \[[@pone.0236034.ref026]\].

Measures {#sec008}
--------

Indicators of multimorbidity were limited to those NCDs with the greatest burden in the population (i.e. prevalence greater than or equal to 1% in each sex). Following guidance from the 2011 systematic review on multimorbidity measurement by Diederichs and colleagues that related diseases be combined \[[@pone.0236034.ref010]\], cardiovascular disease (i.e. heart disease, myocardial infarction, and circulation problems) and mental health disorders (i.e. depression, anxiety, psychosis, and other mental health problems) were grouped together to enhance data quality. Self-reported diagnosis of bronchitis/pneumonia was used as a proxy indicator of chronic obstructive pulmonary disease (COPD). The final list of 11 conditions included hypertension, obesity, hypercholesterolemia, diabetes, asthma, arthritis, cardiovascular disease, mental health disorders, COPD, stroke, and glaucoma.

Presence or absence of these final 11 conditions was largely based on self-report, with the exception of four diseases (obesity; hypertension; diabetes; hypercholesterolemia) where physical assessments were available and used alone, or in combination with self-reports, to increase measurement validity and reliability. Specifically, objective measurements of height and weight were used to determine obesity status (body mass index, BMI, ≥30 kg/m^2^), in accordance with WHO guidelines \[[@pone.0236034.ref001]\]. Diabetes was defined as having a fasting plasma glucose value ≥7.0 mmol/L (126 mg/dl) or being on medication for raised blood glucose \[[@pone.0236034.ref001]\]. Hypertension was defined as systolic blood pressure ≥140 mmHg and/or diastolic blood pressure ≥90 mmHg or using medication to lower blood pressure \[[@pone.0236034.ref001]\]. Hypercholesterolemia was defined as total cholesterol levels of 5.2 mmol/l or higher or self-reported use of medications to control blood cholesterol \[[@pone.0236034.ref001]\].

Multimorbidity was defined as having two or more of the final list of 11 NCDs. A 2012 systematic review by Fortin and colleagues advised inclusion of at least 2 operational definitions of multimorbidity: (1) presence of two or more diseases; and (2) presence of three or more diseases; noting that the latter definition may be more meaningful for clinicians given that a simple count of 2 or more diseases is less discriminating \[[@pone.0236034.ref004]\]. Accordingly, descriptive analyses also use the latter definition, to allow for identification of individuals with higher needs and greater disease burden \[[@pone.0236034.ref004]\].

Ethics {#sec009}
------

Ethical approval of the JHLS-II survey instruments and procedures was granted by the Ministry of Health, Jamaica and the University of the West Indies.

Statistical approach {#sec010}
--------------------

Analyses were restricted to participants with non-missing information on the 11 NCD multimorbidity indicators. Of the 2,848 respondents who completed the survey, 311 (10.9%) were missing information on one or more of these indicators. There were no statistically significant differences between those with complete and those with missing information on the basis on sex, age or region of residence (all *p*\>0.05). The final analytic sample of 2,551 respondents included 790 males and 1,761 females.

Descriptive statistics were calculated for the overall sample and each sex group, to determine the prevalence of morbidity (from individual NCDs) and multimorbidity. Means with 95% confidence intervals (95% CIs) (for continuous variables), and proportions (for categorial variables) were computed and compared using the Mann-Whitney U test and the Pearson's chi-squared (χ^2^) test, respectively, to examine differences across sex. All analyses were weighted to account for sampling design and non-response as well as differences in the age-sex distribution of the study sample compared to the Jamaican population. Base sampling weights reflected the product of the inverse of the probability of selecting a household and the inverse of the probability of selecting a primary sampling unit, adjusted for non-response. Post-stratification weights were calculated as the number of persons in the Jamaican population between the ages of 15--74 years, represented by each individual in the sample within 5-year age-sex categories.

### Latent class analysis (LCA) {#sec011}

*Identification of the baseline model*. LCA was used to identify discrete, mutually exclusive classes of individuals with distinct multimorbidity patterns, based on the presence or absence of the final list of 11 NCD indicators. In order to identify an optimal baseline model, a sequence of LCA models was examined beginning with a single-class model and adding classes in a stepwise fashion until model fit no longer significantly improved. Models with 1 through 6 classes were fit to the data, with final model selection based on a balance of parsimony, substantive consideration of each model and comparison of a range of model fit indices. To ensure that the global maximum (rather than local maximum) was identified, an iterative maximum likelihood estimate was used, with a minimum of 200 'random' sets of starting values \[[@pone.0236034.ref028],[@pone.0236034.ref029]\]. The number of random sets was increased as needed to achieve model identification (i.e. one frequently occurring, dominant solution where the log-likelihood and parameter estimates are replicated) \[[@pone.0236034.ref028],[@pone.0236034.ref029]\].

Several indices were used to guide model selection, including the likelihood-ratio G^2^ statistic, the Akaike Information Criteria (AIC), the Bayesian Information Criteria (BIC) and the adjusted BIC \[[@pone.0236034.ref029],[@pone.0236034.ref030]\]. The likelihood-ratio G^2^ statistic (and parametric bootstrap likelihood ratio test) were used to test the null hypothesis that the specified LCA model fit the data (i.e. a significant p-value indicated that the null model was too restrictive) \[[@pone.0236034.ref028],[@pone.0236034.ref029]\]. Lower values on the information criteria were indicative of a more optimal balance between model fit and parsimony \[[@pone.0236034.ref028],[@pone.0236034.ref029]\]; greatest weight was given to the AIC following evidence from simulation studies of serious underfitting of the BIC, particularly with smaller samples and more unequal class sizes \[[@pone.0236034.ref031],[@pone.0236034.ref032]\]. Substantive interpretability was considered via inspection of probability plots to ensure that resultant solutions were distinguishable, non-trivial in size, and meaningful \[[@pone.0236034.ref029]\]. The prevalence of each latent class was calculated as the average across participant-specific class membership probabilities \[[@pone.0236034.ref029]\]. Once the baseline model had been selected, participants were assigned to their best fit class based on their maximum posterior probability and the mean posterior probability of each latent class calculated as an indicator of classification certainty \[[@pone.0236034.ref033]\]. Mean posterior probabilities above 70% indicated optimal fit \[[@pone.0236034.ref016]\].

Given the potential for obesity to have a double impact, as a *risk factor* for individual NCDs and as a *disease* requiring intervention, sensitivity analyses explored patterns of multimorbidity based on 10 of the 11 NCD indicators listed above (i.e. excluding obesity).

*Testing measurement invariance across sex*. Following guidelines by Lanza et al (2007) which recommend that analyses begin by first fitting a baseline model with no grouping variable \[[@pone.0236034.ref029]\], sex was added as a grouping variable after the baseline model had been selected, to test the hypothesis that multimorbidity patterns vary across sex. To test measurement invariance empirically, the model was run with all parameters freely estimated and again with item-response probabilities constrained equal across groups. The difference in the G^2^ statistic between the two models was compared to the chi-square distribution for the difference in the models' degrees of freedom, and a significant p-value indicated different patterns across groups \[[@pone.0236034.ref028],[@pone.0236034.ref029]\].

### Exploratory factor analysis (EFA) {#sec012}

EFA was used as a robustness check to examine similarities and/or differences in multimorbidity patterns identified using this latent modelling technique and the latent class approach. Consistent with the definition of multimorbidity as the coexistence of two or more diseases, an identified factor needed consist of at least two diseases to qualify as a multimorbidity pattern. Based on examples used in previous studies \[[@pone.0236034.ref006],[@pone.0236034.ref034]\], along with the recommendations from systematic reviews \[[@pone.0236034.ref004],[@pone.0236034.ref010]\], the following criteria were applied during EFA: only those NCDs with a prevalence ≥1% in each sex were included; data on NCDs were coded in binary form and tetra-choric correlation matrices used, owing to the dichotomous nature of the NCD variables; and the principal components extraction method applied. The principal components extraction method allowed for determination of the number of factors to retain, in combination with eigenvalues \>1 and scree plots to visually guide selection. Finally, owing to correlations between NCDs, the oblique rotation method was used to evaluate the factor solution and facilitate interpretation of factor loadings. Factor loadings \>0.3 were taken as the minimum acceptable value for a significant correlation in the identification of diseases comprising each multimorbidity pattern. The Kaiser-Meyer-Olkin (KMO) statistic was used as a measure of sample adequacy \[[@pone.0236034.ref035],[@pone.0236034.ref036]\].

All statistical analyses were carried out via Stata v.15 software, using the LCA Stata Plugin \[[@pone.0236034.ref037]\] and LCA Bootstrap Stata macro \[[@pone.0236034.ref038]\] as needed, with statistical significance indicated by a *p*-value \<0.05.

Results {#sec013}
=======

Sample description {#sec014}
------------------

Of the 11 NCD indicators included in the LCA, two diseases had an overall prevalence of about 25.0%, four had a prevalence between 5.0%--12.0%, while the remaining five had lower prevalence, typically under 5.0% ([Fig 1](#pone.0236034.g001){ref-type="fig"}). Among this sample of the Jamaican population, hypertension was the most prevalent NCD (25.3%), followed by obesity (25.2%), hypercholesterolemia (11.5%), diabetes (7.9%) and asthma (6.9%). About one third (30.6%) of the sample reported only one NCD while nearly one-quarter (24.1%) reported multimorbidity (i.e. two or more diseases). When the more discriminating definition of multimorbidity was applied, approximately 1 in every 10 participants (10.2%) reported at least 3 NCDs.

![Prevalence of non-communicable diseases (NCDs), by sex (JHLS-II data, 2007/2008; N = 2,551).](pone.0236034.g001){#pone.0236034.g001}

The multimorbidity burden was significantly greater in females (p\<0.001), regardless of the definition used. In addition, there were statistically significant sex differences in the prevalence of obesity (females:37.8% vs. males:12.0%; *p*\<0.001), hypercholesterolemia (females:15.3% vs. males:7.5%; *p*\<0.001), diabetes (females:9.2% vs. males:6.5%; *p*\<0.05), arthritis (females:8.2% vs. males:2.1%; *p*\<0.001), and cardiovascular disease (females:6.7% vs. males:2.4%; *p*\<0.001), with the burden in females often 2 to 3 times as high as that in males. On average, females reported 1.2 NCDs (95% CI: 1.1--1.3) while males reported 0.7 diseases (95% CI: 0.6--0.7) (*p*\<0.001).

LCA baseline model {#sec015}
------------------

The LCA model fit results are summarized in [Table 1](#pone.0236034.t001){ref-type="table"}.

10.1371/journal.pone.0236034.t001

###### Summary of information for selecting number of multimorbidity latent classes (JHLS-II data, 2007/2008; N = 2,551).

![](pone.0236034.t001){#pone.0236034.t001g}

  Number of Latent Classes   G^2^                  *df*   AIC      BIC      Adjusted BIC   log-likelihood   Entropy
  -------------------------- --------------------- ------ -------- -------- -------------- ---------------- ---------
  1                          1318.4                2036   1340.4   1404.7   1369.8         -8186.5          1.0
  2                          597.8                 2024   643.8    778.2    705.1          -7826.1          0.7
  3                          524.6                 2012   594.6    799.2    688.0          -7789.6          0.5
  4                          467.0                 2000   561.0    835.7    686.4          -7760.8          0.6
  5                          Not well identified                                                            
  6                          Not well identified                                                            

df = degrees of freedom; AIC = Akaike Information Criterion, BIC = Bayesian Information Criterion.

The G^2^ statistic, AIC and adjusted BIC consistently decreased up until the four-class model while the BIC reached a minimum in the two-class model. Neither models with five nor six classes were well identified---meaning that even after increasing the random starts so that the estimation procedure went through a maximum set of 400 iterations, neither model converged on the same solution the majority of the time. Notably, while the adjusted BIC indicated that the 4-class model was the best fit model, it suggested relatively little difference between this and the three-class model (adjusted BIC~4class~ = 686.4 vs. adjusted BIC~3class~ = 688.0; difference = 1.6). Nonetheless, the four-class model was better identified than the three-class model, with the maximum likelihood estimate converging on the same solution 97.5% of the time (compared to 55.0% of the time for the three-class solution). The four-class solution's entropy score (0.6) indicated greater precision in class prediction (compared to the three-class solution) and, upon examination, allowed for meaningful interpretation of latent classes. Results of the parametric bootstrap likelihood ratio tests ([Table 2](#pone.0236034.t002){ref-type="table"}) further supported this decision, finding statistically significant differences for all except the four-class null model and the alternative five-class model (*p* = 0.33), indicating that the four-class model was the optimum baseline model.

10.1371/journal.pone.0236034.t002

###### Model comparison for selecting the number of multimorbidity latent classes (JHLS-II data, 2007/2008; N = 2,551).

![](pone.0236034.t002){#pone.0236034.t002g}

  Null model   vs.   Alternative model   *p*-value
  ------------ ----- ------------------- -----------
  1-class            2-class             0.01
  2-class            3-class             0.01
  3-class            4-class             0.01
  4-class            5-class             0.33

Latent class prevalences and item-response probabilities (i.e. the estimated probability of reporting a particular NCD, given membership in a particular latent class) for the four-class model are graphed in [Fig 2](#pone.0236034.g002){ref-type="fig"}.

![Item-response probabilities for the four-class model (JHLS-II data, 2007/2008; N = 2,551).](pone.0236034.g002){#pone.0236034.g002}

*Class 1* was labelled *Relatively Healthy* as it was characterized by individuals with low probabilities of all 11 NCDs. The majority of sample respondents (52.7%) were classified into this relatively healthy class. The mean number of NCDs was 0.4. *Class 2* was characterized by individuals with a high probability of hypertension and obesity, and somewhat moderate probability of hypercholesterolemia. This class was labelled *Metabolic* and comprised 30.9% of the sample. The mean number of NCDs in this *Metabolic* class was 1.6. Approximately one in five (19.8%) participants in this class had at least three NCDs. *Class 3* was characterized by individuals with a very high probability of hypertension, obesity, hypercholesteremia and diabetes. Specifically, members of Class 3 had a higher probability of these four NCDs than all other classes. Class 3 was also marked by an increased likelihood of arthritis and cardiovascular disease. This class was labelled *Vascular-Inflammatory* and comprised 12.2% of the sample. The mean number of NCDs was 3.4. The final class, *Class 4*, was characterized by individuals with the highest probability of asthma and COPD and was accordingly labelled *Respiratory*. This was the smallest of all classes, comprising 4.2% of the sample. The mean number of NCDs for the *Respiratory* class was 2.9.

The mean posterior probabilities for all four classes exceeded 0.7 (0.8 for the *Relatively Healthy* class; 0.8 for the *Metabolic* class; 0.9 for the *Vascular-Inflammatory* class; and 0.8 for the *Respiratory* class) suggesting optimal classification.

Sensitivity analyses exploring multimorbidity patterns using only 10 NCDs (i.e. excluding obesity), corroborated findings from the original baseline model with 11 NCD indicators. Specifically, LCA model fit statistics and results of the parametric bootstrap likelihood ratio test ([S1 Table](#pone.0236034.s002){ref-type="supplementary-material"}) all pointed to the 4-class model as the optimal baseline solution. Further, results of the four-class solution suggested that the latent classes were similarly characterized as *Relatively Healthy*, *Metabolic*, *Vascular-Inflammatory* and *Respiratory* based on the item-response probabilities; although a larger proportion of the sample was classified as being *Relatively Healthy* (with an almost negligible probability of reporting any NCD) and a smaller proportion was classified as having multimorbidity (see [S1 Fig](#pone.0236034.s003){ref-type="supplementary-material"}).

Measurement invariance {#sec016}
----------------------

To test measurement invariance across sex, the four-class solution was estimated, first using a model with all parameters free to vary across groups and, second, in a model with the item-response probabilities constrained equal across groups ([Table 3](#pone.0236034.t003){ref-type="table"}).

10.1371/journal.pone.0236034.t003

###### Fit statistics for test of measurement invariance across sex (JHLS-II data, 2007/2008; N = 2,551).

![](pone.0236034.t003){#pone.0236034.t003g}

                                                                          G^2^    *df*   AIC     BIC      Adjusted BIC   log-likelihood
  ----------------------------------------------------------------------- ------- ------ ------- -------- -------------- ----------------
  Model 1: Item-response probabilities free to vary across genders        595.1   4001   783.1   1332.5   1033.8         -7580.7
  Model 2: Item-response probabilities constrained equal across genders   725.7   4045   825.7   1118.0   959.1          -7646.0
  G^2^(~2~)---G^2^(~1~) = 130.6, df = 44, *p* \<0.01                                                                     

df = degrees of freedom; AIC = Akaike Information Criterion, BIC = Bayesian Information Criterion.

The G^2^ difference test was significant (G^2^(~2~)---G^2^(~1~) = 130.6, df = 44, *p* \<0.01), suggesting that measurement invariance across sex did not hold and that the two groups should be modelled separately. Accordingly, a series of models were fit to individual male and female datasets to further investigate the driver of differences with the identified four-class latent structure. [Table 4](#pone.0236034.t004){ref-type="table"} shows the model fit statistics for the male and female subsamples, separately.

10.1371/journal.pone.0236034.t004

###### Summary of information for selecting the number of multimorbidity latent classes for male and female subsamples (JHLS-II data, 2007/2008; N = 2,551).

![](pone.0236034.t004){#pone.0236034.t004g}

  ------------------------------ --------------------- ---------- --------- --------- ------------------ -------------------- -------------
  **Males only (N = 790)**                                                                                                    
  **No. of Latent Classes**      **G**^**2**^**\***    ***df***   **AIC**   **BIC**   **Adjusted BIC**   **log-likelihood**   **Entropy**
  1                              445.9                 2036       467.9     519.3     484.4              -1952.8              1.0
  2                              279.3                 2024       325.3     432.8     359.7              -1869.5              0.6
  3                              221.0                 2012       291.0     454.5     343.3              -1840.3              0.8
  4                              187.6                 2000       281.6     501.2     351.9              -1823.7              0.8
  5                              Not well identified                                                                          
  6                              Not well identified                                                                          
  **Females only (N = 1,761)**                                                                                                
  **No. of Latent Classes**      **G**^**2**^**\***    ***df***   **AIC**   **BIC**   **Adjusted BIC**   **log-likelihood**   **Entropy**
  1                              1028.5                2036       1050.5    1110.8    1075.8             -6081.9              1.0
  2                              490.5                 2024       536.5     662.4     589.3              -5812.9              0.6
  3                              441.4                 2012       511.4     702.9     591.8              -5788.4              0.6
  4                              407.4                 2000       501.4     758.7     609.4              -5771.4              0.6
  5                              Not well identified                                                                          
  6                              Not well identified                                                                          
  ------------------------------ --------------------- ---------- --------- --------- ------------------ -------------------- -------------

df = degrees of freedom; AIC = Akaike Information Criterion, BIC = Bayesian Information Criterion

For both the male and female cohort, the AIC suggested a 4-class model while the BIC suggested the 2-class model. However, for the male cohort, the adjusted BIC reached a minimum with the 3-class model while, for the female cohort, it did so with the 2-class model. Based on the AIC for each subsample, in addition to examination of the distribution of item-response probabilities across all solutions, the 4-class model appeared to provide the best interpretability in each case. Parametric bootstrap analyses further supported this conclusion indicating that, for each subsample, the alternative 5-class model performed no better than the 4-class one (*p*~males~ = 0.38; *p*~females~ = 0.35). The 4-class model was thus selected as the baseline model for optimal balance of model fit, parsimony and ease of interpretation.

For both males ([Fig 3](#pone.0236034.g003){ref-type="fig"}) and females ([Fig 4](#pone.0236034.g004){ref-type="fig"}), multimorbidity patterns generally mimicked the baseline model identified for the general population with differences, however, in both the prevalence of classes as well as the NCDs likely to be reported within each class.

![Item-response probabilities for the four-class model (JHLS-II data, 2007/2008; Males only: n = 790).](pone.0236034.g003){#pone.0236034.g003}

![Item-response probabilities for the four-class model (JHLS-II data, 2007/2008; Females only: n = 1,761).](pone.0236034.g004){#pone.0236034.g004}

Specifically, for males, the *Relatively Healthy* class comprised the majority of the sample (62.0%) and was characterized by individuals with an almost negligible probability of reporting any of the 11 NCDs. On the other hand, the *Relatively Healthy* class comprised just under half of the female sample (49.0%) and was characterized by individuals with a low probability of reporting any NCDs except obesity. The mean number of NCDs reported in this *Relatively Healthy* class was 0.3 and 0.6 for males and females, respectively. Almost equal proportions of the male and female subsamples (males: 32.1%; females: 31.8%) were classified into the second *Metabolic* class. Among males, however, hypertension was the only NCD of high probability while, among females, there was an increased likelihood of reporting hypertension and obesity. The mean number of NCDs reported in the *Metabolic* class was 1.4 and 1.9 for males and females, respectively. Only 3.0% of the male subsample was classified into the third *Vascular-Inflammatory* class, which was characterized by an increased probability of reporting hypertension, diabetes, cardiovascular disease, obesity, arthritis and stroke. In contrast, 14.7% of the female subsample was classified into the *Vascular-Inflammatory* class, which was characterized by an increased probability of reporting hypertension, obesity, arthritis, cardiovascular disease, hypercholesterolemia and diabetes. The mean number of NCDs reported in the *Vascular-Inflammatory* class was 3.8 and 3.6 for males and females, respectively. The final *Respiratory class* was characterized by individuals with a high probability of reporting obesity, asthma and COPD, comprising 2.9% and 4.5% of the male and female subsamples, respectively. The mean number of NCDs reported was 3.3 and 2.7 for males and females, respectively.

Exploratory factor analysis (EFA) results {#sec017}
-----------------------------------------

Adequacy of the sample for factor analysis was confirmed by the KMO statistic of 0.7, which exceeded the recommended value of 0.6 \[[@pone.0236034.ref035],[@pone.0236034.ref036]\]. Results supported evidence of three factors (i.e. multimorbidity patterns), with identification of three components with Eigenvalues greater than one. The scree plot showed the first major inflection (i.e. elbow) at the third factor, suggesting a similar retention of three factors for final analysis ([Fig 5](#pone.0236034.g005){ref-type="fig"}).

![Scree plot of eigenvalues (JHLS-II data, 2007/2008; N = 2,551).](pone.0236034.g005){#pone.0236034.g005}

The three-factor solution collectively explained 60.3% of the variance of the total model, with each component explaining 29.7%, 19.3% and 11.3% of the variance, respectively. Following rotation, a simpler structure was identified with strong factor loadings on each of the three components, all having absolute values above the acceptable threshold of 0.3 ([Table 5](#pone.0236034.t005){ref-type="table"}). Two NCDs (arthritis and cardiovascular disease) showed strong correlations with more than one factor (i.e. multimorbidity patterns).

10.1371/journal.pone.0236034.t005

###### Factor scores and pattern matrix (JHLS-II data, 2007/2008; N = 2,551) for the 11 conditions of multimorbidity.

![](pone.0236034.t005){#pone.0236034.t005g}

                            Factor 1: Vascular   Factor 2: Respiratory   Factor 3: Cardio-Mental-Articular
  ------------------------- -------------------- ----------------------- -----------------------------------
  Hypertension              0.76                                         
  Obesity                   0.50                                         
  Hypercholesterolemia      0.61                                         
  Diabetes                  0.71                                         
  Asthma                                         0.34                    -0.57
  Arthritis                                      0.31                    0.61
  Cardiovascular disease    0.32                                         0.69
  Mental health disorders                                                0.68
  COPD                                           0.92                    
  Stroke                    0.79                                         
  Glaucoma                                       0.95                    

Extraction method: Principal component analysis. Rotation method: Oblique oblimin with Kaiser normalization.

Three multimorbidity patterns were identified in the Jamaican population using EFA: "vascular" (hypertension, obesity, hypercholesterolemia, diabetes, and stroke); "respiratory" (asthma and COPD), and "cardio-mental-articular" (cardiovascular disease, arthritis, and mental health disorders).

Discussion {#sec018}
==========

The burden of multimorbidity in the Caribbean has not yet been well described and this study is the first to use an LCA model to examine multimorbidity prevalence and patterns in the Jamaican population or the wider Caribbean region. Based on data on the presence or absence of 11 NCDs, four classes were identified, including a predominant *Relatively Healthy* class comprising 52.1% of the sample population and characterized by minimal disease. The other three classes were characterized by high burden of multimorbidity and, based on identified patterns, were labelled *Metabolic*, *Vascular-Inflammatory* and *Respiratory*. The resultant classes suggested an almost quantitative dimension to multimorbidity patterns (i.e. the average number of NCDs reported was higher with progressive classes), in addition to more distinct, qualitative differences in the types of diseases comprising the patterns (e.g. *Metabolic* vs. *Respiratory* classes).

Of note, the four diseases whose presence was determined using physical assessments (obesity, hypertension, diabetes, hypercholesterolemia) were primary contributors to multimorbidity patterns, particularly the *Metabolic* and *Vascular-Inflammatory* patterns. This may reflect greater certainty in objectively measured conditions. There was also a very high likelihood of reporting obesity across all multimorbidity classes. Sensitivity analyses, demonstrating that models with and without obesity were qualitatively similar, not only support the patterns identified but indicate the importance of obesity in increasing vulnerability to the accumulation of multiple chronic conditions in this population. This may explain the added vulnerability of women to the burden of multimorbidity, given that the prevalence of obesity among females is over three times as high as that in males. From a programmatic perspective, this finding also highlights the need to better target obesity, which has been identified as major public health problem throughout Jamaica \[[@pone.0236034.ref039],[@pone.0236034.ref040]\], and the wider Caribbean region \[[@pone.0236034.ref041]--[@pone.0236034.ref043]\]. Indeed, while NCD prevention and control efforts should focus on addressing the complex needs of persons with multimorbidity, by supporting them to manage their existing conditions and prevent the accumulation of additional ones, activities need also focus on the *Relatively Healthy* subgroup for whom the presence of obesity may predispose to a multiplicity of chronic disorders. Evidence of high prevalence of obesity among Caribbean children and adolescents \[[@pone.0236034.ref041],[@pone.0236034.ref044]--[@pone.0236034.ref046]\] further underscores the need for urgent intervention.

With regard to identified sex differences in this study population, findings suggest a similar structure in the overall patterning of multimorbidity among males and females, with some key differences in both the absolute burden of multimorbidity as well as the types of diseases comprising multimorbidity profiles among each sex. For example, while nearly two-thirds (62.0%) of the male sample was classified as *Relatively Healthy* with little probability of reporting any NCDs, the same was true for only about half (49.0%) of the female population. Further, the *Vascular-Inflammatory* class was considerably smaller among males (males = 3.0%; females = 14.7%) and was additionally characterized by a high likelihood of reporting stroke---suggesting that despite relatively low overall prevalence of this pattern, males with this disease profile may be at increased risk for complications, physical impairment and functional decline.

It is challenging to compare the results described here to findings from other studies, given differences in the number and type of disease indicators used to define multimorbidity, the types of populations sampled, and the statistical methods applied. Even among studies that have applied LCA to exploration of multimorbidity patterns, comparisons remain difficult since those studies were often limited to older population subgroups and included different disease spectra. Yet, among studies using LCA, results from this analysis were very similar to patterns identified in a population-based survey of Danish adults, aged 16 years and over, which identified seven classes with different disease patterns, based on 15 NCD indicators \[[@pone.0236034.ref009]\]. Specifically, comparable proportions of the samples (Jamaica~15-74\ years~: 53% vs. Denmark~≥16\ years~: 59%) were classified as *Relatively Healthy* with minimal probability of reporting any NCD, while the *Metabolic*, *Respiratory* and *Vascular-Inflammatory* classes identified in this study were qualitatively similar to the "Hypertension", "Complex Respiratory Disorders", "Complex Cardio-metabolic Disorders" classes, respectively, from the Danish study \[[@pone.0236034.ref009]\]. Although the Danish study identified three additional multimorbidity patterns \[[@pone.0236034.ref009]\], these disease profiles were likely not observed in the Jamaican sample since the presence/absence of diseases comprising these patterns (e.g. osteoporosis, slipped discs/other back injuries, migraine/recurrent headache, tinnitus, allergy) was not assessed in the JHLS-II survey.

In comparison to studies applying EFA to the exploration of multimorbidity, similarities in patterns are also observed. For example, one global study of multimorbidity patterns---using data on a cross-sectional sample of adults older than 50 years from the Collaborative Research on Ageing in Europe (COURAGE) project (in Finland, Poland, and Spain) as well as the WHO Study on Global Ageing and Adult Health (SAGE) survey (in China, Ghana, India, Mexico, Russia, and South Africa)--similarly observed a "Metabolic" (diabetes, obesity and hypertension) pattern of relevance to eight of the countries studied (i.e. China, Finland, Ghana, India, Poland, Russia, South Africa, Spain) as well as a "Respiratory" (asthma and COPD) pattern which was only relevant to two (i.e. Finland and Russia) \[[@pone.0236034.ref047]\]. Additional patterns, included a "cardio-respiratory" (i.e. angina, asthma, COPD) pattern of relevance to 7 of the countries studied (i.e. China, Ghana, India, Mexico, Poland, South Africa, Spain) and a "mental-articular" (i.e. arthritis, depression) pattern observed in 3 countries (i.e. China, Ghana, India) \[[@pone.0236034.ref047]\]. Evidence from high-income settings throughout Europe \[[@pone.0236034.ref006],[@pone.0236034.ref009],[@pone.0236034.ref034]\], North America \[[@pone.0236034.ref013],[@pone.0236034.ref015]\], and Australia \[[@pone.0236034.ref011],[@pone.0236034.ref012]\], have similarly demonstrated important differences in the type, prevalence and distribution of co-occurring conditions across populations. These results suggest that while clustering of diseases does exist, identification of context-specific multimorbidity patterns can enable better appreciation of disease burden and profiles, to meaningfully inform strategies aimed at prevention and control.

Comparison of LCA vs. EFA {#sec019}
-------------------------

In this study, results from EFA were generally consistent with findings from LCA, with some minor differences. Both techniques identified three distinct *multimorbidity* patterns and suggested a prominence of two specific patterns of diseases (i.e. a respiratory pattern and a vascular pattern). The main difference was that in LCA there was a *Vascular-Inflammatory* class characterized by hypertension, obesity, hypercholesterolemia, diabetes, cardiovascular disease, and arthritis while, in EFA, the "vascular" pattern also included stroke but did not include arthritis. In fact, in EFA, a "cardio-mental-articular" factor emerged which included cardiovascular disease, arthritis, and mental health disorders. This factor was similar to the "mental-articular" (arthritis, depression) pattern described in above-mentioned global study \[[@pone.0236034.ref047]\], in addition to evidence from systematic reviews of multimorbidity patterns identified via EFA \[[@pone.0236034.ref007],[@pone.0236034.ref048]\].

Observed differences between the EFA and LCA techniques may be attributed to the variable-centered approach of the former which is based on correlations between NCD indicators. Scientists have noted that EFA may also be problematic for binary data, which may be grouped owing to similar distributions rather than any common underlying features \[[@pone.0236034.ref018]\]. Conversely, the probabilistic LCA model uses a person-centered approach that may be more useful for strategic intervention planning by providing knowledge of the likelihood of individuals presenting with similar disease profiles. Indeed, LCA allowed for a more nuanced appreciation of two multimorbidity profiles---that is, a *Metabolic* class, with a strong likelihood of metabolic disorders only (e.g. hypertension, obesity) and another *Vascular-inflammatory* class where the probability of these two metabolic disorders was even higher and also coupled with increased likelihood of diabetes, hypercholesterolemia, arthritis and cardiovascular disease. This finding may suggest that the *Metabolic* subgroup is at risk of progression to a more severe *Vascular-Inflammatory* disease pattern where the burden of multimorbidity is higher. Although, empirical analyses indicate that those in the *Metabolic* group were significantly younger than those in the *Vascular-Inflammatory* group (mean age ~Metabolic~ = 46.1 vs. mean age ~Vascular-Inflammatory~ = 56.5; *p*\<0.001), such a conclusion cannot be confirmed using the current study as longitudinal data is needed to explore risk of transitioning from one class to another.

Strengths and limitations {#sec020}
-------------------------

This is the first study to assess profiles of co-occurrence of morbidities in Jamaica, or the larger Caribbean region. Via identification of distinct combinations, rather than simple counts of diseases, this study offers a richer and more nuanced understanding of multimorbidity prevalence and patterns in Jamaica, providing insight into the nature and severity of the NCD burden. It also adds to the evidence base of the multimorbidity burden in LMICs, providing data that is more comparable for other island nations which are similarly heavily affected by NCDs. Yet, there are several limitations. First, females outnumbered males nearly 2:1 in the final analytic sample and generalizability of results to the larger Jamaican population may be limited by the smaller proportion of males. Sex-specific LCA analyses may have also been limited by the small male subsample. Further, there is some degree of classification uncertainty in LCA \[[@pone.0236034.ref033]\] while different software packages have been noted to result in structurally different cluster solutions \[[@pone.0236034.ref049]\]. These limitations should be borne in mind in interpretation of results. Replication of our findings in future studies using larger samples would add further support for patterns identified.

Secondly, although use of both subjective self-reports and objective assessment may have increased reliability in measurement of four NCDs (hypertension, obesity, hypercholesterolemia, diabetes), accuracy in reporting of the other seven NCDs may have been affected by various factors. For example, inaccurate self-reporting of prevalent mental health disorders is noted in the literature \[[@pone.0236034.ref050]\] and may reflect diseases being undiagnosed or failure of participants to disclose their conditions to interviewers, while diseases such as asthma tend to be more commonly diagnosed in children and youth \[[@pone.0236034.ref051]\]. Another limitation is that this study was unable to assess either disease severity or the presence/absence of pain, both of which may not only influence participant self-reports but also serve as important indicators of disease control and individual capacity. The decision to include self-reported bronchitis/pneumonia as a proxy for COPD may not be supported by other researchers who may query inclusion of this disease type within the NCD umbrella. Further, given that the final list of 11 conditions was based largely on convenience and limited to those NCDs identified in the JHLS-II survey questionnaire, it is likely that different multimorbidity profiles may have emerged if other NCD indicators had been used. Notably, however, in the absence of a gold standard measure for multimorbidity, adherence to recommended standards, which advise inclusion of between 11--12 most prevalent chronic diseases in a given population \[[@pone.0236034.ref004],[@pone.0236034.ref010]\], is a major strength of this study. This study included all diseases specified in the recommended list, with the exception of cancer---given its lower overall prevalence in the sample population.

Finally, while use of population-level data increased the representativeness of identified patterns, the study design which excluded age-groups older than 74 years may have introduced a selection and information bias. It is well-recognized that multimorbidity assumes greater importance with advancing age \[[@pone.0236034.ref004],[@pone.0236034.ref007],[@pone.0236034.ref010]\] and failure to examine variations in patterns as people age omits an important population demographic where multimorbidity may be more common, with greater implications for disease severity, management of conditions, functional status and quality of life.

Conclusion {#sec021}
==========

The findings indicate that a considerable proportion of the population is managing two or more conditions, with a female preponderance in the burden and degree of multimorbidity. Consistency of multimorbidity patterns identified here with results from other international studies supports the non-random association of diseases and the need for intervention to better control and support, if not prevent, the inevitable lifelong management of multiple diseases with which many populations must contend. Future work using longitudinal datasets would enable exploration of disease trajectories and understanding of how individuals manage multiple conditions and transition to different patterns over time. Investigation of multimorbidity burden in other LMICs is also needed to better reflect individual burden of disease as well as clinician's daily workload and experience. As future research continues to examine this multimorbidity phenomenon, exploration into the causes and consequences of NCD patterns, with attention to variation in disease profiles according to sex, age and socio-economic status, can guide the development of strategies that allow for more targeted prevention and intervention.

Supporting information {#sec022}
======================

###### Data underlying the present analyses.

(XLS)

###### 

Click here for additional data file.

###### Model comparison for selecting number of multimorbidity latent classes based on 10 indicators (JHLS-II data, 2007/2008; N = 2,551).

This LCA model excludes obesity.

(PDF)

###### 

Click here for additional data file.

###### Item-response probabilities for the latent class model based on 10 indicators (JHLS-II data, 2007/2008; N = 2,551).

This LCA model excludes obesity.

(TIF)

###### 

Click here for additional data file.
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Reviewer \#1: General remark: This article examines the patterns of multimorbidity among the adult population of Jamaica. The authors use advanced statistical techniques to analyze data and the paper is well written. I find the study interesting, but there are some methodological weaknesses in the study that I think should be addressed.

Page 8, line 147 ff.

The following description in the manuscript of the sample weighting procedure could leave the expression that the weighted sample is representative of the Jamaican population:

\"The final analytic sample of 2,551 respondents included 790 males and 1,761 females ... All analyses were weighted to account for sampling design and non-response as well as differences in the age-sex distribution of the study sample compared to the Jamaican population. Base sampling weights reflected the product of the inverse of the probability of selecting a household and the inverse of the selecting a primary sampling unit, adjusted for non-response. Post-stratification weights were calculated as the number of persons in the Jamaican population between the ages of 15-74 years represented by each individual in the sample within 5-year age-sex categories.\"

However, when this reviewer calculated the proportion of males using the attached data file, the unweighted percentage of males was 30.97 while the weighted percentage was 31.55 (using the variable sampwt_adj as weight). This indicates that the weighted results are far from representative of the Jamaican adult population (49% of the population were men according to Wilks R, Younger N, Tulloch-reid M, Mcfarlane S, Francis D (2008) Jamaica Health and Lifestyle Survey 2007-8. Kingston: Tropical Medicine Research Institute, University of the West Indies). This could potentially have far-reaching consequences for the quality of the study. The authors should comment on this. Is it possible to generalize the results to the entire population?

Page 8, line 214

\"All statistical analyses were carried out via Stata v.15 software, using the LCA Stata Plugin ...\"

It is well-known that different LCA-programs may come up with different cluster solutions (cf. Haughton, Dominique & Legrand, Pascal & Woolford, Sam. (2009). Review of three latent class cluster analysis packages: Latent gold, poLCA, and MCLUST. The American Statistician. 63. 81-91. 10.1198/tast.2009.0016.)

The most widely used LCA programs are LatentGOLD and MPlus. I tried to repeat the LCA analysis on page 12 using LatentGOLD (without and with weights). The results differ from the results in Table 1, see below:

File name:S1 Data.sav

File size:2551 records

File date:2020-feb-610:06:55

LLBIC(LL)AIC(LL)NparL²dfp-valueClass.Err.

UNWEIGHTED

Model11-Cluster-23246924649533464940711374390,120362,9e-785550

Model22-Cluster-22223704445051444478723169745,820243,4e-344780,0997

Model33-Cluster-22119714424414442401235148947,520121,7e-300300,1956

Model44-Cluster-22037994408232440769147132602,720006,3e-265430,2154

Model55-Cluster-2199355439950643988285912371519887,7e-246540,2047

Model66-Cluster-2195780439251843917027111656519761,6e-231370,2345

Model77-Cluster-21937114388541438758783112426,719645,8e-222650,3091

WEIGHTED

Model81-Cluster-8247,8116581,9216517,63111315,148203610

Model92-Cluster-7876,2315932,8915798,4723571,9874202410,1051

Model103-Cluster-7836,3815947,3115742,7635492,2788201210,1635

Model114-Cluster-7810,715990,0815715,447440,9214200010,221

Model125-Cluster-7797,7316058,2715713,4659414,9783198810,2792

Model136-Cluster-7786,2116129,3615714,4171391,9334197610,279

Model147-Cluster-7775,1516201,3715716,383369,8185196410,2633

In the example with unweighted data, BIC and AIC did not reach a minimum among models with 1-7 latent classes. In the example with the weighted data, a minimum is reached for BIC with a three-cluster solution and for AIC with a five-cluster solution. Compared to this, in Table 1, models with more than four classes are not well identified. I suggest that the authors consider running the analysis again with another LCA program to ensure that results are stable.

Reviewer \#2: Craig et al. intended to estimate the prevalence of multimorbidity, identify population subgroups with similar disease profiles, and examine consistency in patterns with different statistical approaches. They analyzed 2,551 subjects and observed a high burden of co-existing conditions that is predominantly borne by female.

1.Line 152 Pearson "?". What statistic? Pearson correlation statistics? Spell out the full name. if it's Pearson correlation, then please explain how it can be used to examine differences across sex as stated in the manuscript.

2\. Line 307, "in addition to examination of the distribution of item-response probabilities across all solutions, the 4-class model appeared to provide the best interpretability in each case." As the discrepancy was observed from different criteria, it requires more explanation how this conclusion was reached. The argument based on the interpretation is somewhat rather subjective!

3.In the exploratory factor analysis, three factors were identified. The LCA, four were identified. Why did authors conclude the consistent results among different approach?

4.The EFA was only performed for all sample. The comparison for the sex-specific analysis should be conduct as the discrepancies were identified earlier.

Reviewer \#3: This in an interesting paper, however I have few comments to authors as follows.

Although the title of the paper indicates the paper focused on identifying patterns of multimorbidity, the objectives includes measure the prevalence, identifying the patterns of multimorbidity and comparing between the methods. Including multiple objectives has prevented the authors to produce rigorous results and conclusion for the paper. I would recommend the author keep the main objective in according to the title of the paper. The author should decide which methods (LCA or EFA) as the main approach used to identify the pattern of multimorbidity of course with the justification for the decision, the other can be used as a robustness check for their results.

While the authors provided reference to link with other source where study designs and data collection were described, the method of this paper does not have information on study design, data collection and study population to justify for whether the data is sufficient to address the aim of this study. I think the author should include the information in the paper.

Lines 145-147: "There were no statistically significant differences 146 between those with complete and those with missing information on the basis on sex, age or region of 147 residence (data not shown)". How about the difference between the study population and the target population whether the sampling frame used?

The two methods were used to identify the patterns of multimorbidity, however, I don't find any justification for why the authors used the method. What are the contribution of the methods in identifying the patterns? If you intend to compare both methods to see which one is better to use, the simulated data with a known pattern of multimorbidity should be used instead of the current dataset where the true pattern is unknown.

Four classes of multimorbidity were identified in the paper, it would be more informative if the authors have further details of what are the characteristics of the classes such as age, social economic status etc. Whether the characteristics are significant different across the classes of multimorbidity.

\*\*\*\*\*\*\*\*\*\*

6\. PLOS authors have the option to publish the peer review history of their article ([what does this mean?](https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history)). If published, this will include your full peer review and any attached files.

If you choose "no", your identity will remain anonymous but your review may still be made public.

**Do you want your identity to be public for this peer review?** For information about this choice, including consent withdrawal, please see our [Privacy Policy](https://www.plos.org/privacy-policy).

Reviewer \#1: No

Reviewer \#2: No

Reviewer \#3: No

\[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link \"View Attachments\". If this link does not appear, there are no attachment files to be viewed.\]
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Reviewer \#1

General remark: This article examines the patterns of multimorbidity among the adult population of Jamaica. The authors use advanced statistical techniques to analyze data and the paper is well written. I find the study interesting, but there are some methodological weaknesses in the study that I think should be addressed.

Page 8, line 147 ff.

The following description in the manuscript of the sample weighting procedure could leave the impression that the weighted sample is representative of the Jamaican population:

\"The final analytic sample of 2,551 respondents included 790 males and 1,761 females. All analyses were weighted to account for sampling design and non-response as well as differences in the age-sex distribution of the study sample compared to the Jamaican population. Base sampling weights reflected the product of the inverse of the probability of selecting a household and the inverse of the selecting a primary sampling unit, adjusted for non-response. Post-stratification weights were calculated as the number of persons in the Jamaican population between the ages of 15-74 years represented by each individual in the sample within 5-year age-sex categories.\"

However, when this reviewer calculated the proportion of males using the attached data file, the unweighted percentage of males was 30.97 while the weighted percentage was 31.55 (using the variable sampwt_adj as weight). This indicates that the weighted results are far from representative of the Jamaican adult population (49% of the population were men according to Wilks R, Younger N, Tulloch-Reid M, Mcfarlane S, Francis D (2008) Jamaica Health and Lifestyle Survey 2007-8. Kingston: Tropical Medicine Research Institute, University of the West Indies). This could potentially have far-reaching consequences for the quality of the study. The authors should comment on this. Is it possible to generalize the results to the entire population?

Response:

This is an important point. The reviewer is correct that based on the (un)weighted percentage of males (\~31%) in the sample, females outnumber males nearly 2:1. Of note, the JHLS-II study investigators created sampling weights, including post-stratification weights, that attempt to compensate for sampling inadequacies and, when used, yield age-specific proportions which are in keeping with national statistics (Wilks, Younger, Tulloch-Reid, Mcfarlane, & Francis, 2008). This adds support that the data remain nationally representative. Nonetheless, we agree that potential limitations regarding generalizability of results should be acknowledged and have done so in the Discussion section.

Page 8, line 214

\"All statistical analyses were carried out via Stata v.15 software, using the LCA Stata Plugin.\"

It is well-known that different LCA-programs may come up with different cluster solutions (cf. Haughton, Dominique & Legrand, Pascal & Woolford, Sam. (2009). Review of three latent class cluster analysis packages: Latent gold, poLCA, and MCLUST. The American Statistician. 63. 81-91. 10.1198/tast.2009.0016.) The most widely used LCA programs are LatentGOLD and MPlus. I tried to repeat the LCA analysis on page 12 using LatentGOLD (without and with weights). The results differ from the results in Table 1, see below:

File name: S1 Data.sav

File size: 2551 records

File date: 2020-feb-6 10:06:55

LL BIC(LL) AIC(LL) Npar L² df p-value Class.Err.

UNWEIGHTED

Model1 1-Cluster -2324692 4649533 4649407 11 374390,1 2036 2,9e-78555 0

Model2 2-Cluster -2222370 4445051 4444787 23 169745,8 2024 3,4e-34478 0,0997

Model3 3-Cluster -2211971 4424414 4424012 35 148947,5 2012 1,7e-30030 0,1956

Model4 4-Cluster -2203799 4408232 4407691 47 132602,7 2000 6,3e-26543 0,2154

Model5 5-Cluster -2199355 4399506 4398828 59 123715 1988 7,7e-24654 0,2047

Model6 6-Cluster -2195780 4392518 4391702 71 116565 1976 1,6e-23137 0,2345

Model7 7-Cluster -2193711 4388541 4387587 83 112426,7 1964 5,8e-22265 0,3091

WEIGHTED

Model8 1-Cluster -8247,81 16581,92 16517,63 11 1315,148 2036 1 0

Model9 2-Cluster -7876,23 15932,89 15798,47 23 571,9874 2024 1 0,1051

Model10 3-Cluster -7836,38 15947,31 15742,76 35 492,2788 2012 1 0,1635

Model11 4-Cluster -7810,7 15990,08 15715,4 47 440,9214 2000 1 0,221

Model12 5-Cluster -7797,73 16058,27 15713,46 59 414,9783 1988 1 0,2792

Model13 6-Cluster -7786,21 16129,36 15714,41 71 391,9334 1976 1 0,279

Model14 7-Cluster -7775,15 16201,37 15716,3 83 369,8185 1964 1 0,2633

In the example with unweighted data, BIC and AIC did not reach a minimum among models with 1-7 latent classes. In the example with the weighted data, a minimum is reached for BIC with a three-cluster solution and for AIC with a five-cluster solution. Compared to this, in Table 1, models with more than four classes are not well identified. I suggest that the authors consider running the analysis again with another LCA program to ensure that results are stable.

Response:

This is another excellent point. Unfortunately, we do not have access to any of the LCA programs you note (i.e., LatentGOLD, MPlus). We do, however, have access to SAS software and have repeated analyses using this statistical package. Results are presented below:

UNWEIGHTED

\# of Classes G2 df AIC BIC Adjusted BIC log-likelihood

1 1315.15 2036 1337.15 1401.43 1366.48 -8247.81

2 571.98 2024 617.98 752.40 679.32 -7876.23

3 498.37 2012 568.37 772.92 661.71 -7839.42

4 440.86 2000 534.86 809.54 660.21 -7810.67

5 NOT WELL IDENTIFIED

6 395.27 1976 537.27 952.21 726.63 -7787.88

WEIGHTED

\# Latent Classes G2 df AIC BIC Adjusted BIC log-likelihood

1 1318.43 2036 1340.43 1404.71 1369.76 -8186.47

2 597.76 2024 643.76 778.18 705.10 -7826.14

3 524.52 2012 594.52 799.07 687.87 -7789.52

4 466.96 2000 560.96 835.64 686.31 -7760.74

5 435.66 1988 553.66 898.47 711.01 -7745.09

6 410.48 1976 552.48 967.42 741.84 -7732.5

As is the case with your weighted example and the results presented in the manuscript, the BIC reached a minimum with the 2-class solution for both unweighted and weighted analyses in SAS. As noted in the manuscript, however, while we considered information criteria together with substantive interpretability (i.e., that resultant solutions were distinguishable, non-trivial in size, and meaningful) to determine the best fit solution, greater weight was given to the AIC and adjusted BIC following evidence from simulation studies of serious underfitting of the BIC, particularly with smaller samples and more unequal class sizes (Dziak, Coffman, Lanza, Li, & Jermiin, 2019; Nylund, Asparouhov, & Muthén, 2007).

For the unweighted SAS analyses, both the AIC and adjusted BIC reach a minimum with the 4-class model. This is in keeping with the results presented in the manuscript. Also, the 5-class model is similarly not well identified in the SAS example (i.e. the model did not converge in 5,000 iterations) and, while the 6-class model is well-identified in the SAS model, none of the information criteria indicate better fit over the 4-class solution. Differences in model identification for analyses performed in SAS and Stata (and perhaps in the LatentGOLD results the reviewer provides above) may reflect Stata not exceeding a maximum set of 400 iterations.

For the weighted SAS analyses, the AIC and adjusted BIC suggested 6-class and 4-class solutions, respectively. Of note, however, the 6-class solution did not meet criteria for substantive interpretability (i.e., classes were neither distinguishable, non-trivial in size, nor meaningful). Results of the 6-class solution in SAS are presented below to illustrate this point:

Class Prevalences 1 2 3 4 5 6

0.47 0.23 0.10 0.16 0.02 0.02

Item-response probabilities 1 2 3 4 5 6

Hypertension 0.01 0.51 0.88 0.59 0.24 0.10

Obesity 0.18 0.68 0.57 0.00 0.26 0.50

Hypercholesterolemia 0.05 0.23 0.42 0.16 0.00 0.24

Diabetes 0.00 0.15 0.42 0.14 0.08 0.06

Asthma 0.08 0.06 0.05 0.00 0.08 0.43

Arthritis 0.03 0.10 0.41 0.00 0.23 0.02

CVD 0.00 0.00 0.42 0.00 1.00 0.12

Mental health disorders 0.03 0.02 0.08 0.01 0.07 0.13

COPD 0.02 0.00 0.06 0.00 0.03 1.00

Stroke 0.00 0.00 0.12 0.02 0.00 0.00

Glaucoma 0.00 0.00 0.07 0.04 0.07 0.00

Please note also that weighted and unweighted analyses in Stata yielded qualitatively similar results -- that is, identifying the 4-class model comprising Relatively Healthy, Metabolic, Vascular-Inflammatory and Respiratory classes as the best fit model.

Nonetheless, we thank the reviewer for this comment as the concern raised regarding different LCA programs leading to different solutions is an important one. We have added mention of this in the Discussion section, including reference to the Haughton et al (2009) article kindly suggested by the reviewer, noting potential limitations of our analyses and implications for future work applying LCA techniques.

Reviewer \#2

Craig et al. intended to estimate the prevalence of multimorbidity, identify population subgroups with similar disease profiles, and examine consistency in patterns with different statistical approaches. They analyzed 2,551 subjects and observed a high burden of co-existing conditions that is predominantly borne by females.

1.Line 152 Pearson \"?\". What statistic? Pearson correlation statistics? Spell out the full name. if it\'s Pearson correlation, then please explain how it can be used to examine differences across sex as stated in the manuscript.

Response:

Thank you for this comment. This should have read "Pearson\'s chi-squared (ꭓ2) test". This test was used to examine differences in the prevalence of single and multiple morbidities across sex. It has been corrected in the text.

2\. Line 307, \"in addition to examination of the distribution of item-response probabilities across all solutions, the 4-class model appeared to provide the best interpretability in each case.\" As the discrepancy was observed from different criteria, it requires more explanation how this conclusion was reached. The argument based on the interpretation is somewhat rather subjective!

Response:

We are thankful to the reviewer for making this important point. Indeed, the selection of the best fit solution for the male and female subsamples were not as clear based on information criteria alone. Specifically, in the sex-specific analyses, "... the AIC suggested a 4-class model while the BIC suggested the 2-class model. However, for the male cohort, the adjusted BIC reached a minimum with the 3-class model while, for the female cohort, it did so with the 2-class model."

As noted in the manuscript, we did give greater weight to the AIC and the adjusted BIC following evidence from simulation studies of serious underfitting of the BIC, particularly with smaller samples and more unequal class sizes (Dziak et al., 2019; Nylund et al., 2007). Further, as guided by recommendations from Collins and Lanza (Collins & Lanza, 2010) on determination of the best fit solution, we ensured that our final decision-making was informed by thorough evaluation of a wide range of available information. This included examination of substantive interpretability (i.e., ensuring that resultant solutions were distinguishable, non-trivial in size, and meaningful), comparison of entropy scores (to reflect classification certainty and model precision) and use of parametric bootstrap likelihood ratio tests (to test the null hypothesis that the specified LCA model fit the data) (S. Lanza & Rhoades, 2013; S. T. Lanza, Collins, Lemmon, & Schafer, 2007). Collectively, these criteria and parameters gave greater support for the 4-class model. Yet, the reviewer is correct that this final determination is somewhat subjective. In light of this important point, we have added a sentence to the Discussion section acknowledging the need for replication in future work with larger samples.

3.In the exploratory factor analysis, three factors were identified. The LCA, four were identified. Why did authors conclude the consistent results among different approach?

Response:

This is an excellent point. The number of patterns (i.e. classes vs. factors) observed speak to the differences in the two statistical approaches. Both techniques identified three multimorbidity patterns. LCA revealed three multimorbidity profiles in addition to a no disease or single morbidity profile (i.e. 4 classes in total). EFA revealed 3 multimorbidity factors -- just as LCA did. The EFA approach would not have identified a no disease or single morbidity factor since strong, stable factors typically contain at least three strongly loading items (i.e., items with factor loadings ≥0.5) (Costello & Osbourne, 2005). (Of note, in this study, we specified that 2 items were sufficient for identification of a factor given the current definition of multimorbidity as the simultaneous presence of two or more diseases.)

4.The EFA was only performed for all sample. The comparison for the sex-specific analysis should be conduct as the discrepancies were identified earlier.

Response:

Thank you, this is another excellent point. We chose not to present sex-specific EFA analyses given the many results already presented in the paper, along with previously acknowledged sample size limitations (i.e., the small male subsample) and cautioning that EFA is a "large-sample" procedure (Costello & Osbourne, 2005). Yet, results from sex-specific analyses were qualitatively similar to EFA results on the full sample, identifying "vascular"; "respiratory", and "cardio-mental-articular" factors. Results were also consistent with LCA subgroup analyses. Specifically, among men, the vascular factor (which was qualitatively similar to the Vascular-Inflammatory class) included hypertension, diabetes, cardiovascular disease, obesity and stroke while, among females, this factor included hypertension, obesity, hypercholesterolemia and diabetes.

Men Women

Vascular Respiratory Cardio-Mental-Articular Vascular Respiratory Cardio-Mental-Articular

Hypertension 0.62 0.81

Obesity 0.60 0.50

Hypercholesterolemia 0.70 0.63

Diabetes 0.77 0.70

Asthma 0.94 0.33 -0.50

Arthritis 0.77 0.41 0.61

CVD 0.77 0.38 0.68

Mental health disorders -0.88 0.64

COPD -0.39 0.55 0.46 0.79 -0.31

Stroke 0.74 0.47 0.64 -0.71

Glaucoma 0.76 0.35 0.96

Reviewer \#3

This in an interesting paper, however I have few comments to the authors as follows.

Although the title of the paper indicates the paper focused on identifying patterns of multimorbidity, the objectives include measuring the prevalence, identifying the patterns of multimorbidity and comparing between the methods. Including multiple objectives has prevented the authors to produce rigorous results and conclusion for the paper. I would recommend the author keep the main objective in, according to the title of the paper. The author should decide which methods (LCA or EFA) is the main approach used to identify the pattern of multimorbidity, of course with the justification for the decision; the other can be used as a robustness check for their results.

Response:

This is an important point and we appreciate the reviewer's comments. The title has been revised to "Prevalence and patterns of multimorbidity in the Jamaican population: A comparative analysis of latent variable models". We believe this title better captures the aims which the paper attempts to address.

We have also revised the paper throughout to better reflect the goals of this manuscript in describing the prevalence and patterns of multimorbidity in the Jamaican population, using LCA as the main modelling approach, with EFA used to examine whether results are robust to variation in how multimorbidity patterns are analyzed.

While the authors provided a reference to link with another source where study designs and data collection were described, the method of this paper does not have information on study design, data collection and study population to justify whether the data is sufficient to address the aim of this study. I think the author should include the information in the paper.

Response:

Thank you for this important comment. In the revised manuscript, we now provide more details on the study design and sampling strategy for this nationally representative survey.

Lines 145-147: \"There were no statistically significant differences 146 between those with complete and those with missing information on the basis on sex, age or region of 147 residence (data not shown)\". How about the difference between the study population and the target population whether the sampling frame used?

Response:

This is an important point and we thank the reviewer for this comment. As a secondary data analysis, we do not have access to the sampling frame used; however, we do acknowledge that previous researchers have noted that errors in the sampling frame are possible and may account for the excess of females in the sample as well as lower representation of some age-groups than would be expected based on population statistics (Tulloch-Reid et al., 2013; Wilks et al., 2008). Notably, however, post-stratification weights were designed by the JHLS-II study investigators to account for sampling inadequacies and, when used, yield age-specific proportions that are in keeping with national statistics and add support for the comparability and representativeness of data (Wilks et al., 2008). Revisions to the Discussion section address important considerations for the representativeness of study findings.

The two methods were used to identify the patterns of multimorbidity, however, I don\'t find any justification for why the authors used the method. What are the contribution of the methods in identifying the patterns? If you intend to compare both methods to see which one is better to use, the simulated data with a known pattern of multimorbidity should be used instead of the current dataset where the true pattern is unknown.

Response:

Thank you for this comment. The choice to use LCA was based on its person-centered approach, combined with evidence of its increasing application to studies on multimorbidity patterns. However, among identified gaps and next steps for multimorbidity research, scientists have consistently called for context-specific multimorbidity studies that also "increase the reliability of findings through comparison of statistical techniques." We thus chose to compare LCA results with those from EFA since the latter method is also a latent modelling technique and has been cited as one of the commonly used methods (aside from simple counts) for examining multimorbidity patterns. The reviewer makes a great point with regard to true patterns and simulated data. As the first study, to our knowledge, to examine patterns of multimorbidity in a Caribbean population, true patterns were unfortunately unknown at the time of this research. We have thus revised the text to better clarify the additional use of EFA, not merely as a comparison technique but also as a robustness check. We have also revised the manuscript to note that future replication studies could provide additional support for patterns identified.

Four classes of multimorbidity were identified in the paper, it would be more informative if the authors have further details of what are the characteristics of the classes such as age, social economic status etc. Whether the characteristics are significantly different across the classes of multimorbidity.

Response:

This is an excellent point and the authors agree that information on the social profiles of multimorbidity would be very informative. Unfortunately, given the many aims described in this paper, an in-depth exploration of social determinants was beyond the scope of this manuscript. However, further analyses describing the social determinants of the identified patterns are underway.
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